Acquiring Company
Elanco Animal Health
Acquired Company
Kindred Biosciences
IndianapolisSan FranciscoManufacturingBiotechnologyAgriculture and FarmingHealth CareAnimal FeedPetVeterinaryPharmaceutical ManufacturingBiotechnologyHealth CareBiopharmaDescription
Elanco Animal Health has completed its acquisition of Kindred Biosciences for approximately $440 million. The deal reflects a total equity value that rewards shareholders for Kindred's advancements in veterinary biologics. The acquisition aims to enhance Elanco's product offerings in the growing veterinary therapeutics market.
Quick answer
Elanco Animal Health is acquiring Kindred Biosciences, announced July 17, 2026. Elanco Animal Health is based in Indianapolis, Indiana, United States.
- How much did Elanco Animal Health pay for Kindred Biosciences?
- The deal value was not disclosed.
- What does Elanco Animal Health do?
- Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for..
- Where are Elanco Animal Health and Kindred Biosciences based?
- Elanco Animal Health is based in Indianapolis, Indiana, United States. Kindred Biosciences is based in San Francisco, California, United States.
- Who are the decision-makers at Elanco Animal Health?
- Fundz holds 1 contact at Elanco Animal Health. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Animal Feed
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- PetVivo Holdings acquires PiezoBioMembrane for growth (June 24, 2026)
- Curaleaf to acquire Aurora Cannabis for $272 million, $272M (August 16, 2026)
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Zoetis to acquire Neogen Corporation amid competition concerns (July 28, 2026)
- Zoetis to acquire VitalRADS for diagnostics boost (July 14, 2026)
Who to call at Elanco Animal Health, and when
When Elanco Animal Health changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Elanco Animal Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elanco Animal Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elanco Animal Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elanco Animal Health makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kindred Biosciences?
Kindred Biosciences was acquired by Elanco Animal Health, based in Indianapolis. The deal was reported on July 17, 2026. Elanco Animal Health is publicly traded (ELAN) and operates in Manufacturing.
When did Elanco Animal Health acquire Kindred Biosciences?
Elanco Animal Health's acquisition of Kindred Biosciences was reported on July 17, 2026. Elanco Animal Health has completed its acquisition of Kindred Biosciences for approximately $440 million. The deal reflects a total equity value that rewards shareholders for Kindred's advancements in veterinary biologics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kindred Biosciences do?
Kindred Biosciences is a biopharmaceutical company dedicated to saving and improving the lives of animals. Specializing in developing innovative product therapies, they focus on veterinary medicines for companion animals. It is privately held, operating in Biotechnology, and is based in San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.